HealthEquity Other Long-Term Assets 2014-2024 | HQY

HealthEquity other long-term assets from 2014 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • HealthEquity other long-term assets for the quarter ending July 31, 2024 were $0.065B, a 24.12% increase year-over-year.
  • HealthEquity other long-term assets for 2024 were $0.068B, a 30.07% increase from 2023.
  • HealthEquity other long-term assets for 2023 were $0.052B, a 4.76% increase from 2022.
  • HealthEquity other long-term assets for 2022 were $0.05B, a 33.1% increase from 2021.
HealthEquity Annual Other Long-Term Assets
(Millions of US $)
2024 $68
2023 $52
2022 $50
2021 $37
2020 $35
2019 $21
2018 $2
2017 $2
2016 $2
2015 $0
2014 $
2013 $
HealthEquity Quarterly Other Long-Term Assets
(Millions of US $)
2024-07-31 $65
2024-04-30 $69
2024-01-31 $68
2023-10-31 $52
2023-07-31 $53
2023-04-30 $53
2023-01-31 $52
2022-10-31 $48
2022-07-31 $49
2022-04-30 $49
2022-01-31 $50
2021-10-31 $45
2021-07-31 $43
2021-04-30 $39
2021-01-31 $37
2020-10-31 $34
2020-07-31 $35
2020-04-30 $35
2020-01-31 $35
2019-10-31 $34
2019-07-31 $22
2019-04-30 $22
2019-01-31 $21
2018-10-31 $18
2018-07-31 $18
2018-04-30 $18
2018-01-31 $2
2017-10-31 $2
2017-07-31 $2
2017-04-30 $2
2017-01-31 $2
2016-10-31 $2
2016-07-31 $2
2016-04-30 $2
2016-01-31 $2
2015-10-31
2015-07-31
2015-04-30
2015-01-31 $0
2014-10-31
2014-07-31
2014-04-30
2014-01-31
2013-10-31
2013-07-31
2013-01-31 $1
Sector Industry Market Cap Revenue
Medical Medical Services $8.629B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.015B 12.16
Cencora (COR) United States $48.948B 18.05
DiDi Global (DIDIY) China $23.622B 0.00
ICON (ICLR) Ireland $17.731B 15.79
Natera (NTRA) United States $16.587B 0.00
Viatris (VTRS) United States $15.469B 4.76
Avantor (AVTR) United States $15.375B 23.05
Revvity (RVTY) United States $14.905B 25.89
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.590B 0.00
Solventum (SOLV) United States $12.509B 0.00
Medpace Holdings (MEDP) United States $11.276B 31.77
Charles River Laboratories (CRL) United States $11.014B 21.28
Doximity (DOCS) United States $10.815B 64.01
Sonic Healthcare (SKHHY) Australia $8.542B 0.00
Bausch + Lomb (BLCO) Canada $7.043B 32.79
Life Times (LTH) United States $5.170B 34.22
Sotera Health (SHC) United States $4.557B 24.38
Organon (OGN) United States $4.131B 4.17
Surgery Partners (SGRY) United States $3.859B 42.76
BrightSpring Health Services (BTSG) United States $3.408B 72.48
PACS (PACS) United States $3.251B 0.00
Alignment Healthcare (ALHC) United States $2.620B 0.00
Concentras Parent (CON) United States $2.500B 0.00
Ardent Health Partners (ARDT) United States $2.337B 0.00
Premier (PINC) United States $2.292B 11.44
GeneDx Holdings (WGS) United States $2.137B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.589B 0.00
Progyny (PGNY) United States $1.499B 26.37
Pediatrix Medical (MD) United States $1.353B 13.24
Establishment Labs Holdings (ESTA) $1.292B 0.00
CareDx (CDNA) United States $1.268B 0.00
AMN Healthcare Services Inc (AMN) United States $1.104B 7.49
Embecta (EMBC) United States $0.897B 5.98
InnovAge Holding (INNV) United States $0.813B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.757B 0.00
SBC Medicals (SBC) United States $0.706B 0.00
Auna S.A (AUNA) Luxembourg $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.469B 0.00
DocGo (DCGO) United States $0.409B 15.38
Enhabit (EHAB) United States $0.397B 34.30
COMPASS Pathways (CMPS) United Kingdom $0.373B 0.00
LifeMD (LFMD) United States $0.252B 0.00
Sera Prognostics (SERA) United States $0.225B 0.00
ModivCare (MODV) United States $0.221B 12.05
Beauty Health (SKIN) United States $0.202B 0.00
Biodesix (BDSX) United States $0.199B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.129B 0.00
So-Young (SY) China $0.089B 21.63
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.055B 0.00
OncoCyte (OCX) United States $0.048B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.036B 0.00
IceCure Medical (ICCM) Israel $0.030B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00